Chief Financial Officer · Immuneering Corp (IMRX)

Biren Amin

FY2021 is the first fiscal year CompBrief holds for Biren Amin as a named executive officer of Immuneering; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,273,530

Salary $312,500Stock awards $0Bonus $180,000

1st of 3 named executive officers at Immuneering by FY2021 total.

3 named officers on file for Immuneering, FY2021

Biren Amin’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Immuneering’s whole pay program stands against its peers

  • Immuneering’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IMRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 2, 2022 (DEF 14A).

Free

Get Biren Amin’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Biren Amin compensation by year

Immuneering Summary Compensation Table · the one fiscal year held
In US dollars, as Immuneering reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$312,500
Bonus$180,000
Stock awards$0
Option awards$2,769,472
Non-equity incentive$0
Pension and deferred compensation$0
All other$11,558
Total$3,273,530

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immuneering Corp DEF 14A filed May 2, 2022, accession 0001104659-22-054083, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Immuneering Corp filed document, accession 0001104659-22-054083. Every figure is read from that document and cited to the page and table it appears in. Filed May 2, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option284,340—$9.74

Per the Outstanding Equity Awards at Fiscal Year-End table in Immuneering Corp's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Immuneering’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Biren Amin · this pageChief Financial Officer$3,273,530
Benjamin ZeskindPresident and Chief Executive Officer$2,544,271
Brett HallChief Scientific Officer$2,524,190

The full Immuneering compensation record

free company brief

This page is one person within Immuneering's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Immuneering's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Biren Amin's compensation dossier · One-time report. No refunds.